Genenta plans by-law and board changes vote

Genenta Science S.p.A. has called an Ordinary and Extraordinary Shareholders’ Meeting for October 29, 2025 in virtual format, with a second-call date on October 30, 2025 if needed.

Rhea-AI Filing Summary

Genenta Science S.p.A. has called an Ordinary and Extraordinary Shareholders’ Meeting for October 29, 2025 in virtual format, with a second-call date on October 30, 2025 if needed. Shareholders will be asked to approve amendments to Article 4 of the company’s by-laws to expand its corporate purpose to include all sectors covered by Italian Golden Power legislation.

They will also vote on increasing the Board of Directors from three to five members and on the appointment of two new board members. The notice of meeting and related materials are to be posted on Genenta’s website under the Investors section on or about September 10, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Genenta Science (GNTA) announcing in this Form 6-K?

Genenta Science S.p.A. is informing investors about an upcoming Ordinary and Extraordinary Shareholders’ Meeting where shareholders will vote on by-law amendments and Board changes.

When will Genenta Science’s 2025 Shareholders’ Meeting take place?

The meeting is scheduled in virtual format for October 29, 2025 at 6:00 PM CET on first call, and October 30, 2025 at 6:00 PM CET on second call, if required.

What by-law change is Genenta Science (GNTA) proposing to shareholders?

Shareholders will be asked to approve amendments to Article 4 of the company’s by-laws to extend the corporate purpose to include all sectors covered by Italian Golden Power legislation.

How will the Genenta Science Board of Directors change if the proposals are approved?

The proposals include increasing the size of the Board of Directors from three members to five members and approving the appointment of two additional board members.

Where can investors find the Genenta Science shareholders’ meeting notice and materials?

The notice and other materials related to the Ordinary and Extraordinary Shareholders’ Meeting will be posted on the company’s website at www.genenta.com under the Investors tab.

What exhibit is attached to this Genenta Science Form 6-K?

The Form 6-K includes Exhibit 99.1, which is the Notice of Call of Ordinary and Extraordinary Shareholders Meeting dated September 8, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/10/2025 - 04:05 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-41115

GENENTA SCIENCE S.P.A.

(Translation of registrant’s name into English)

Via Olgettina No. 58

20132 Milan, Italy

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐

Other Events

On September 10, 2025, Genenta Science S.p.A. (the “Company”) issued a notice (“Notice”) regarding its Ordinary and Extraordinary Shareholders’ Meeting to be held in virtual meeting format on October 29, 2025 at 6:00 PM CET on first call, and second call on October 30, 2025 at 6:00 PM CET, if required. At the Ordinary and Extraordinary Shareholders’ Meeting, the Company’s shareholders will be asked to: (1) approve amendments to Article 4 of the Company’s by-laws to extend the Company’s corporate purpose in order to include all sectors covered by the Italian Golden Power legislation (Extraordinary session); (2) approve the increase in the size of the Board of Directors from three (3) members to five (5) members (Ordinary session); and (3) approve the appointment of two (2) board members (Ordinary session). The Notice and other materials related to its upcoming Ordinary and Extraordinary Shareholders’ Meeting will be posted on the Company’s website at www.genenta.com under the Investors tab on or about September 10, 2025.

Exhibits.

Exhibit No.		Description
99.1		Notice of Call of Ordinary and Extraordinary Shareholders Meeting dated September 8, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	GENENTA SCIENCE S.P.A.
	By:	/s/ Richard B. Slansky
	Name:	Richard B. Slansky
	Title:	Chief Financial Officer

Dated: September 10, 2025